CVRx (CVRX) Other financing activities (2022 - 2026)

CVRx (CVRX) recorded quarterly Other financing activities of $1.1 million in Q1 2026, up 55250.0% quarter-over-quarter from $2000.0 in Q4 2024.

CVRx (CVRX) Other financing activities (2022 - 2026) Analysis & Trends

CVRx's Other financing activities history runs 4 years deep, the most recent figure standing at $1.1 million for Q1 2026.

  • In Q1 2026, Other financing activities changed N/A year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $1.1 million (up 629.61% YoY), while the FY2024 annual figure was $152000.0, down 15.08% from the prior year.
  • Other financing activities was $1.1 million for Q1 2026 at CVRx, up from $2000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $1.1 million in Q1 2026 to a low of $2000.0 in Q4 2024.
  • Historically, Other financing activities has averaged $316571.4 across 4 years, with a median of $112000.0 in 2023.
  • The sharpest annual moves came in 2023 and 2024: Other financing activities plunged 85.6% in 2023, then tumbled 98.21% in 2024.
  • A 4-year view of Other financing activities shows it stood at $778000.0 in 2022, then slumped by 85.6% to $112000.0 in 2023, then sank by 98.21% to $2000.0 in 2024, then jumped by 55250.0% to $1.1 million in 2026.
  • The last three Other financing activities figures came in at $1.1 million (Q1 2026), $2000.0 (Q4 2024), and $150000.0 (Q3 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 CVRx 130.46 Mn 58.16 Mn 12.88 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.11 Mn
Mar 31, 2026 1.11 Mn
Dec 31, 2024 2,000.00
Dec 31, 2024 2,000.00
Sep 30, 2024 150,000.00
Sep 30, 2024 150,000.00
Dec 31, 2023 112,000.00
Dec 31, 2023 112,000.00
Jun 30, 2023 7,000.00
Jun 30, 2023 7,000.00
Mar 31, 2023 60,000.00
Mar 31, 2023 60,000.00
Dec 31, 2022 778,000.00
Dec 31, 2022 778,000.00